Alembic Pharma received USFDA approval for diabetes drug

Posted on:17 Oct 2018 11:27:42
Alembic Pharma received USFDA approval for diabetes drug
17 October 2018 Current Affairs:

Alembic Pharmaceuticals received a tentative approval from the United States Food and Drug Administration (USFDA), the U.S. health regulator for its Alogliptin tablets. The drug is used for the treatment of type 2 diabetes.

 The Alogliptin tablets are made in the strengths of 6.25 mg, 12.5 mg and 25mg. The product is a generic version of Takeda Pharms USA’s Nesina tablets.


Alembic Pharmaceuticals received a tentative approval from the United States Food and Drug Administration (USFDA), the U.S. health regulator for its Alogliptin tablets. The drug is used for the treatment of type 2 diabetes.

 The Alogliptin tablets are made in the strengths of 6.25 mg, 12.5 mg and 25mg. The product is a generic version of Takeda Pharms USA’s Nesina tablets.


Monthly Current Affairs


Fresherslive telegram Group

Current Affairs Section

Daily Current Affairs Quiz

Subscribe to Current Affairs

Enter your email to get daily current affairs

Current Affairs Weekly PDF

Current Affairs Monthly PDF

Current Affairs Quiz

Current Affairs Monthly PDF Hindi

Currentt Affairs 2019 January

18 JANUARY
NEWS
17 JANUARY
NEWS
16 JANUARY
NEWS
15 JANUARY
NEWS

Currentt Affairs 2018 December

31 DECEMBER
NEWS
30 DECEMBER
NEWS
29 DECEMBER
NEWS
28 DECEMBER
NEWS

Currentt Affairs 2018 November

30 NOVEMBER
NEWS
29 NOVEMBER
NEWS
28 NOVEMBER
NEWS
27 NOVEMBER
NEWS